The Senate Judiciary Committee removed legislation from its agenda that would have made it more difficult for patent assertion entities (“PAEs”) to pursue infringement claims, likely ...
This special memorandum summarizes the major topics and information discussed by China’s three antitrust agencies during the “Antitrust in Asia: China” conference, co-sponsored by t...
Last September, we circulated a
note highlighting the four merger challenges
that the U.S. antitrust authorities were then pursuing. At the time, we noted that these matters underscore...
The year 2013 marked the fifth anniversary of the implementation of China’s Anti-Monopoly Law (“AML”) and included a number of significant developments in each of the three antitrus...
Exclusive forum provisions in corporate bylaws and certificates of incorporation are back on the agenda for many companies. We reviewed the trend data in a June 2012 briefing and predicte...
While we are all undoubtedly aware of the Department of Justice’s (“DOJ”) pending lawsuit seeking to enjoin the merger of AMR and U.S. Airways, you may be less focused on the fact t...
Articles & Books
Getting the Deal Through – Corporate Governance 2013
This year, we have seen executive compensation issues continue to dominate the global governance agenda, especially in Europe in the wake of the recent Swiss referendum, in which voters a...
Yesterday, Chancellor Leo E. Strine, Jr. of the Delaware Court of Chancery upheld the statutory and contractual validity of bylaws separately adopted by the boards of directors of Chevron...
On June 20, 2013, the Supreme Court decided a case regarding waivers of class arbitration that could have potentially wide-ranging implications in antitrust and other cases. See American ...
On June 17, 2013, the Supreme Court decided a case of considerable importance to the pharmaceutical industry. The case involved the question of whether and to what extent “reverse payme...
